Ironwood Pharmaceuticals and Forest Laboratories, Inc. to Present Linaclotide Data at Digestive Disease Week® 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and Forest Laboratories, Inc. (NYSE: FRX) announced today they will present linaclotide-related data during Digestive Disease Week® 2013 in Orlando, Fla., May 18 through May 21, 2013. Among the data highlighted will be two oral presentations: one providing insight into the GC-C/cGMP pathway in patients with IBS-C and another describing the effects of linaclotide on inhibiting visceral pain, both based on nonclinical studies.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC